Bravo-Perez C, Gurnari C. A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS. Semin Hematol. 2024 Feb;61(1):43-50. doi: 10.1053/j.seminhematol.2024.01.004. Epub 2024 Jan 19. PubMed PMID: 38350765.
AÑO: 2024; IF: 5.0
|
Guarnera L, D'Addona M, Bravo-Perez C, Visconte V. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. Int J Mol Sci. 2024 Aug 20;25(16):9023. doi: 10.3390/ijms25169023. Erratum In: Int J Mol Sci. 2024 Nov 01;25(21):11743. doi: 10.3390/ijms252111743. PubMed PMID: 39201709; PubMed Central PMCID: PMC11354696.
AÑO: 2024; IF: 4.9
|
Borsellino B, Bravo-Perez C, Visconte V, Guarnera L. Thrombosis in Myeloid Malignancies: From CHIP to AML. Cardiovasc Hematol Disord Drug Targets. 2024;24(1):2-12. doi: 10.2174/011871529X307253240530060107. PubMed PMID: 38879768.
AÑO: 2024
|
Kawashima N, Kubota Y, Bravo-Perez C, Guarnera L, Williams ND, Durmaz A, Witt M, Ahmed A, Gurnari C, Maciejewski JP, Visconte V. Landscape of biallelic DNMT3A mutant myeloid neoplasms. J Hematol Oncol. 2024 Sep 27;17(1):87. doi: 10.1186/s13045-024-01607-9. PubMed PMID: 39334207; PubMed Central PMCID: PMC11438130.
AÑO: 2024; IF: 29.5
|
Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Perez C, Bagoly Z, Bereczky Z, Trelinski J, Witkowski M, Klajmon A, Undas A, Zabczyk M. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype. Thromb Haemost. 2023 Sep;123(9):880-891. doi: 10.1055/s-0043-1768712. Epub 2023 May 18. PubMed PMID: 37201530; PubMed Central PMCID: PMC10460956.
AÑO: 2023; IF: 5.0
|